FACTS. Federal Office for Safety in Health Care
|
|
- Sara Bryant
- 6 years ago
- Views:
Transcription
1 FACTS Federal Office for Safety in Health Care 1
2 BASG / AGES MEA Federal Office for Safety in Health Care (BASG) and Austrian Medicines and Medical Devices Agency (AGES MEA) The Federal Office for Safety in Health Care (BASG) and the Austrian Medicines and Medical Devices Agency (AGES MEA) were both set up in January The BASG is directly subordinated to the Austrian Federal Ministry of Health and Women (BMGF), carrying out sovereign tasks, including authorisation and control of medicinal products and vigilance of devices. BASG consists of three members appointed by the Federal Minister of Health, one member from BMG and from AGES MEA each. The third member is the head of the AGES MEA. AGES MEA is therefore closely linked to the BASG, constituting two of its members, providing BASG with necessary resources, staff and infrastructure. When carrying out sovereign activities, the employees of AGES MEA are acting on behalf of BASG. Responsibilities of AGES MEA include providing Scientific Advice, inspecting according to GMP, GLP and GCP, assessing dossiers for new marketing authorisations of medicinal products, as well as European surveillance of medicinal products and medical devices already marketed, in terms of efficacy and possible side effects, i.e. pharmacovigilance, and all processes related to Lifecycle-Management. AGES MEA is also monitoring blood-and tissue-vigilance issues. SCIENTIFIC ADVICE Scientific advice for applicants When developing medicines, pharmaceutical companies have the possibility of obtaining scientific advice from AGES MEA. Both types of procedures (EMA Scientific Advice/National Scientific Advice) represent specified focus areas. In the case of enquiries from the field of new substances (chemical and bio), but also from the development of biosimilars and generics, AGES MEA ranks consistantly amongst the leading medicines agencies within the EU. With regard to the number of scientific advice procedures it occupied the 1st placetop-position among all EU agencies. This achievement illustrates impressively the extensive know-how available for applicants and customers of AGES MEA to benefit from. VALUES OF AGES MEA WE ARE RESPONSIBLE WE ARE OBJECTIVE WE ARE COMPETENT WE ARE EUROPEAN Number of EMA Scientific Advice Procedures Processes of the Austrian Medicines and Medical Devices Agency in the Life-Cycle of Medicinal Products Adaptive Pathways Suspension of Marketing Scientific / Regulatory Advice Variations/ Renewals of Marketing Variations of Manufacturing Manufacturing (GMP- Inspections) Safety Signals & Risk Management periodic GMP-Inspections PV-Inspections Market Surveillance Authority Batch Release Assessment of Clinical Trials GLP- & GCP- Inspections Marketing SAWP - Scientific Advice in 2015 Procedures 12% 11% 11% % 9% 9% 9% AT Coordinator AT Peer Review 7% 65 6% 6% % 4% 4% % 3% % 9 AT Member States 2 3
3 CLINICAL TRIALS MARKETING AUTHORISATION of clinical trials Approval procedure - Main areas of focus Core competences of AGES MEA Phases of submitted clinical trials Phase I Phase II Phase III Phase IV AGES MEA conducts a scientific assessment of the chemical, pre-clinical and clinical data of the application for marketing authorisation. This assessment determines the outcome of the decision regarding the approval of a medicine. In recent years emphasis has been placed on these features both with regard to the approval of generics (more than 90 % of all national authorisation applications), as well as in the field of biotechnology. Blood- and plasma products, vaccines, monoclonal antibodies (MAbs), biosimilars and the field of immunology are all core competencies of the AGES MEA. BLOOD- AND PLASMA PRODUCTS VACCINES BIOSIMILAR PRODUCTS Commercial Trials in AT Academic Trials in AT Phase I Phase II 20 Phase I Phase II 50 Phase III Phase IV 10 Phase III Phase IV Numbers Numbers Year Year 4 5
4 AUTHORISATION AND LIFECYCLE- MANAGEMENT OF MEDICINAL PRODUCTS MRP/DCP Procedure AGES MEA plays a sustained and leading role as Rapporteur in the centralised procedure (CP) and as Reference Member State (RMS) in the evaluation of mutual recognition and de-centralised authorisation procedures (MRP/ DCP). For years now, Austria has been in the EU Top 10 in MRP/DCP procedures. Since 2009 Austria has constantly occupied a top ten place in the overall European comparison. Recently Austria also entered Top ten in centralised procedures. This achievement clearly underlines the obvious commitment on the part of the Austrian medical authority to be at the forefront of helping to shape matters at a European level - both in the interest of applicants and of public health. Centralised Procedure Top ten place in European comparison since NL DE UK DK PT SE HU AT ES CZ FI FR NO IS MT IE PL SI SK BE IT EE LV HR LT BG CY EL LU MRP DCP % early finalised, 41% timely finalised Overview on finalised human MR- and DC-procedures per RMS 2016 Fast processing, time kept as short as possible, many DCP procedures can be finalised before day timely finalised early finalised ) Austria in comparison to other agencies per number of Rapporteur and Co-rapporteurships in the centralised procedure Marketing authorisations issued over the last years national vs MRP/DCP MS 1 MS 2 MS 3 MS 4 MS 5 Austria MS 7 MS 8 MS 9 MS 10 MS 11 MS 12 MS 13 MS 14 MS 15 MS 16 MS 17 MS 18 MS 19 MS 20 MS 21 MS 22 MS 23 MS 24 MS 25 MS 26 MS 27 MS 28 MS 29 MS 30 Proced. nat. nat. Proced. MRP&DCP Sum of of procedures finalised 6 7
5 s and Variations OMCL Variations 691 New Market s Batch release Approval of plasma pools New Marketing s Variations (single applications) New Marketing s vs. Variations SURVEILLANCE Market surveillance Inspections Market surveillance: sample structure 2015 Numbers of domestic and foreign countries inspections Samples from: legal market illegal market pharmacopoe development 21 QMM (reports of quality defects) Routine quality control national Routine quality control international domestic inspections foreign inspections TBE Others Total number of human vaccines Influenza Meningococcal group C vaccines Veterinary vaccines Batch Release of vaccines
6 CONTACT BASG & AGES MEA BASG - Federal Office for Safety in Health Care AGES MEA - Austrian Medicines and Medical Devices Agency Traisengasse 5, 1200 Vienna Head of AGES MEA, Procedural Member BASG Dipl.-Ing. Dr. Christa Wirthumer-Hoche basg_anfragen@ages.at +43 (0)
7 12
Austrian Medicines & Medical Devices Agency
Austrian Medicines & Medical Devices Agency MEA Infoveranstaltung 15. 9.2014 DI Dr. Christa Wirthumer-Hoche Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH AGES-Struktur (Stand: 01.07.2014)
More informationEUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems, medical products and innovation Medicines: policy, authorisation and monitoring PHARM 723 PHARMACEUTICAL COMMITTEE 18 October
More informationFuture of Europe Climate change Special Eurobarometer 479
Future of Europe Climate change Special Eurobarometer 479 October-November 2018 Methodology Survey conducted face-to-face at respondents home Fieldwork dates: October 24th to November 7th 2018 Population
More informationGerman Competent Authorities as Part of the Network of European Drug Regulators. PD Dr. Walter Schwerdtfeger
German Competent Authorities as Part of the Network of European Drug Regulators PD Dr. Walter Schwerdtfeger BfArM and PEI: General duties (on the basis of the Federal Health Office Succession Act, June
More informationPharmacovigilance. Maia Uusküla
Pharmacovigilance Maia Uusküla 27.10.2012 PhV activities - Local ADR reports (collection, assessment) - Encouragement of HCPs to report ADRs - Increase knowledge about ADRs - benefit-risk assessment -Assessment
More informationAPPLICATION FOR VARIATION TO A MARKETING AUTHORISATION
Page 1 of 13 May 2008 APPLICATION FOR VARIATION TO A MARKETING AUTHORISATION HUMAN VETERINARY NATIONAL AUTHORISATION IN MRP MRP variation number 1A : / / / / / COMMUNITY AUTHORISATION EMEA variation number
More informationNOTICE TO APPLICANTS. VOLUME 6B Presentation and content of the dossier-part 1 Summary of the dossier Part 1A Application form OCTOBER 2008
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, October 2008 F2/KK D(2008) Revision 7.2 NOTICE TO APPLICANTS Medicinal products for Veterinary Use
More informationMUTUAL RECOGNITION PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT. Kefavet vet 250 mg and 500 mg film coated tablets
MUTUAL RECOGNITION PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT CMDv/TEM/003-02 1/9 MODULE 1 PRODUCT SUMMARY EU Procedure number Name, strength and pharmaceutical form Applicant
More informationNOTICE TO APPLICANTS. VOLUME 6B Presentation and content of the dossier-part 1 Summary of the dossier Part 1A Application form.
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Food and feed safety, innovation Animal nutrition, veterinary medicines Brussels, 29.11.2017 Revision 8 NOTICE TO APPLICANTS Medicinal
More informationMedicinal Products for Human Use. May 2008
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, F2/ (2008) Revision 9 NOTICE TO APPLICANTS Medicinal Products for Human Use VOLUME 2B Module 1:
More informationAustrian Medicines & Medical Devices Agency Role in Centralised Procedures
Austrian Medicines & Medical Devices Agency Role in Centralised Procedures Gerhard Beck Head of Institute Assessment & Analytics Austrian Federal Office for Safety in Health Care www.basg.gv.at Austrian
More informationRenewable energy sources in Slovakia a quantitative assessment and policy conclusion towards, and beyond, 2020
Renewable energy sources in Slovakia a quantitative assessment and policy conclusion towards, and beyond, 2020 Author: Dr. Christian Panzer Company: Vienna University of Technology Energy Economics Group
More informationAnnex 4. Application of Article 23: Wholesalers to decommission on behalf of persons authorised or entitled to supply medicines to the public
Annex 4. Applicati Article 23: Wholesalers to decommissi behalf perss authorised or entitled to medicines to the public Perss retailers Den emergency other AT BE Yes, for to emergency supplies ships Vaccinati
More informationCollege ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg AH Utrecht The Netherlands
MEB agency / Veterinary Medicinal Products Unit The Netherlands C B G M E B College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The
More informationItem 3.2: LCS/LCI consistency. By Hege S. Hauglund and Uwe Pedersen, Statistics Denmark Workshop on Labour Costs, Rome, 5-6 May 2015
Item 3.2: LCS/LCI consistency By Hege S. Hauglund and Uwe Pedersen, Statistics Denmark Workshop on Labour Costs, Rome, 5-6 May 2015 Background For the year 2012 and onwards, annual labour cost levels have
More informationThe EDQM turns 50: to your very good health!
Public health, medicines, Europe The EDQM turns 50: to your very good health! European Directorate for the Quality of Medicines & HealthCare Direction européenne de la qualité du médicament & soins de
More informationEuropean Reference Networks
European Reference Networks Issues addressed and key support developments of the Member States to the networks Till Voigtländer 4 th Conference on European Reference Networks: ERNs in action, Charlemagne
More informationResearch and Development at the heart of a modern economy
Item 15a: Research and Development ESTP course on National Accounts ESA 1 Luxembourg, 15-19 June 15 Research and Development at the heart of a modern economy R&D expenditure represents one of the major
More informationPeriod of time from September 2015 to August Summary of pharmacovigilance system audit report results v3
Report to the European Commission on Pharmacovigilance audits carried out in BASG/AGES (Austrian Federal Office for Safety in Health Care / Austrian Medicines and Medical Devices Agency), Austria Period
More informationANNEX ANNEX. to the. Report from the Commission to the Council and the European Parliament
EUROPEAN COMMISSION Brussels, 8.3.2018 COM(2018) 118 final ANNEX ANNEX to the Report from the Commission to the Council and the European Parliament on the effects of Articles 199a and 199b of Council 2006/112/EC
More informationExternal Price Referencing an European overview
External Price Referencing an European overview Mag. (FH) Christine Leopold, MSc. PPRI conference, 29.09.2011 2011 Disclaimer and acknowlegdements The information and data provided in this presentation
More informationMedicinal Products for Human Use. September 2015
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health Systems and products Brussels, (2015) Revision 12 NOTICE TO APPLICANTS Medicinal Products for Human Use VOLUME 2B Module 1.2: Administrative
More informationURGENT SAFETY RESTRICTION MEMBER STATE STANDARD OPERATING PROCEDURE
Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human URGENT SAFETY RESTRICTION MEMBER STATE STANDARD OPERATING PROCEDURE June 2000 Revision 3, December 2005 This document was
More informationMedicinal Products for Human Use. VOLUME 2B Module 1.2: Administrative information Application form. February 2018
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems, medical products and innovation Revision 13 NOTICE TO APPLICANTS Medicinal Products for Human Use VOLUME 2B Module 1.2: Administrative
More informationAdding value to IRENA s REmap 2030 project using a European Electricity Model
Adding value to IRENA s REmap 2030 project using a European Electricity Model Seán Collins, Deger Saygin, Paul Deane, Dolf Gielen, Brian Ó Gallachóir ESRI-UCC Workshop ESRI 7 th June 2016 Overview Adds
More informationCMD(h) GUIDANCE FOR MAHs ON THE PHARMACOVIGILANCE SYSTEM AND RISK MANAGEMENT PLAN IN THE MUTUAL RECOGNITION & DECENTRALISED PROCEDURES
CMD(h) GUIDANCE FOR MAHs ON THE PHARMACOVIGILANCE SYSTEM AND RISK MANAGEMENT PLAN IN THE MUTUAL RECOGNITION & DECENTRALISED PROCEDURES 1. INTRODUCTION (BACKGROUND) November 2007 According to Article 8
More informationEUMedRail Project - Kick-off Meeting Harmonised Regulation and Standards for Operations and Driver Training
EUMedRail Project - Kick-off Meeting Harmonised Regulation and Standards for Operations and Driver Training 25/10/2017, Brussels Interoperability Unit I. Train Drivers DIRECTIVE 2007/59/EC OF THE EUROPEAN
More informationRole of Official Medicines Control Laboratories (OMCL) in assessing quality of biologicals.
National Center for Immunobiologicals Research and Evaluation (CRIVIB) Rome, Italy Role of Official Medicines Control Laboratories (OMCL) in assessing quality of biologicals. Carlo Pini Head, CRIVIB Disclaimer
More informationThe European Commission s renewable energy proposal
The European Commission s renewable energy proposal 11/13/08 EUROPEAN COMMISSION Tom Howes, European Commission Renewable energy promotion since 1997 National targets for RE electricity since 2001 National
More informationPreparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties.
19 June 2018 CMDh/361/2017, Rev.2 Questions and Answers related to the United Kingdom's withdrawal from the European Union with regard to national authorised medicinal products for human use Introduction
More informationGender segregation in education, training and employment
Gender segregation in education, training and employment Learning seminar: EIGE - EU Social partners 3 July, 2018 Focus of the presentation Subject choices in education and training by gender Gender analysis
More informationHow are medicines evaluated at the EMA
How are medicines evaluated at the EMA Presented by: Nathalie Bere Patient interaction / Stakeholders and communication Division An agency of the European Union The European System Centralised Procedure
More informationRural Development Programmes
Rural Development Programmes 2014-2020 28 Partnership Agreements covering all ESI Funds 2/2 118 RDPs 4/4 15/15 2/2 30/30 23/23 3/3 19/19 Rural Development Funding In total, around 161 billion of total
More informationPublic Assessment Report Scientific discussion. Octanate LV (human coagulation factor VIII) SE/H/1070/03-04/DC
Public Assessment Report Scientific discussion Octanate LV (human coagulation factor VIII) SE/H/1070/03-04/DC This module reflects the scientific discussion for the approval of Octanate LV. The procedure
More informationCAP CONTEXT INDICATORS
CAP CONTEXT INDICATORS 2014-2020 44. ENERGY USE IN AGRICULTURE, FORESTRY AND THE FOOD INDUSTRY 2017 update BE BG CZ DK DE EE IE EL ES FR HR IT CY LV LT LU HU MT NL AT PL PT RO SI SK FI SE UK CONTEXT INDICATOR
More informationPublic Assessment Report Scientific discussion SE/H/171/01/E01/MR
Public Assessment Report Scientific discussion Hemosol B0 (lactic acid, calcium chloride, magnesium chloride, sodium chloride and sodium hydrogen carbonate) SE/H/171/01/E01/MR This module reflects the
More informationThe New Skills Agenda
The New Skills Agenda ECVET Network 21 June 2016 1 Topics of the presentation 1) EU Skills overview Understanding the challenge 2) A New Skills Agenda for Europe: the Commission proposal for EU action
More informationReport from the CMD(h) meeting held on 18 th, 19 th and 20 th June 2007
Report from the meeting held on 18 th, 19 th and 20 th June 2007 Sub-group meeting on Harmonisation of SPCs There was a meeting of the Sub-Group on harmonisation of SPCs, mainly to consider the proposals
More informationAppendix D Comparison of Emissions Data with GAINS
1 Appendix D Comparison of Emissions Data with 2 Comparison of Emissions Data with This section presents a comparison of emissions data from the Installation Database developed in this study and the data
More informationFrequently Asked Questions on E-commerce in the European Union Eurobarometer results
MEMO/08/426 Brussels, 20 June 2008 Frequently Asked Questions on E-commerce in the European Union Eurobarometer results How did these Eurobarometers address e-commerce? The Special Eurobarometer 298 aims
More informationThe importance of quality management in structural reforms. 8 th European CAF User's event Sofia
The importance of quality management in structural reforms 8 th European CAF User's event Sofia I. Link between offer and demand II. Some challenges III. How does Commission deal IV. The SRSS the «new
More informationOperating subsidies (both direct payments and rural development except investment support) 8 March 2018
(both direct payments and rural development except investment support) 8 March 218 This contribution gives an overview of the share of "operating subsidies" in farm income by different dimensions. The
More informationFONASBA Annual Meeting 2010
FONASBA Annual Meeting 2010 EU Customs Union Where are we and where is the EU customs union going Maria Manuela CABRAL DG TAXUD/Unit A1 1 Current situation Implementation of the so-called Safety & Security
More informationNew Challenges for EMA and NCA: News from BfArM
New Challenges for EMA and NCA: News from BfArM Dr. Karl Broich Vicepresident Federal Institute for Drugs (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Agenda / Outline BfArM in the EU Experience
More informationPublic Assessment Report. Scientific discussion
Public Assessment Report Scientific discussion Moxalole Powder for oral solution (Macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride) DK/H/1199/001/DC This module reflects the
More informationWORKERS VOICE IN CORPORATE GOVERNANCE
EUROPEAN DIALOGUE 2016 WORKERS VOICE IN CORPORATE GOVERNANCE A European perspective Aline Conchon Policy Adviser, industriall Europe aline.conchon@industriall-europe.eu MESSAGE #1 IN EUROPE, WORKERS ARE
More informationVOLUME 6A CHAPTER 7 GENERAL INFORMATION. July 2009
Ref. Ares(2014)76601-15/01/2014 EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 01.07.2009 ENTR/F/2/KK D (2008) Revision 9-6 NOTICE TO APPLICANTS
More informationAgencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)
DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT
More informationRenewable energy sources in Greece and the EU a quantitative assessment and policy conclusion towards, and beyond, 2020
Renewable energy sources in Greece and the EU a quantitative assessment and policy conclusion towards, and beyond, 2020 Simone Steinhilber Fraunhofer Institute for Systems and Innovation Research ISI http://www.isi.fraunhofer.de
More informationRegulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG
Please be aware that we cannot guarantee the correctness of the translation. To make sure, you have the correct and complete version, please look at the German version of the official announcements of
More informationRegulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG
Please be aware that we cannot guarantee the correctness of the translation. To make sure, you have the correct and complete version, please look at the German version of the official announcements of
More informationCompany: Richter Pharma AG Feldgasse 19 A Wels DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
BASG - Federal Office for Safety in Health Care AGES - Austrian Agency for Health and Food Safety Traisengasse 5, A-1200 Vienna www.basg.gv.at Company: Feldgasse 19 A - 4600 Wels DECENTRALISED PROCEDURE
More informationPublishing date: 07/02/2018. We appreciate your feedback. Share this document
Publishing date: 07/02/2018 Document title: Electricity and gas retail - List of Figures 2016 We appreciate your feedback Please click on the icon to take a 5 online survey and provide your feedback about
More informationOverview of the New Skills Agenda for Europe. Key elements and actions
Overview of the New Skills Agenda for Europe Key elements and actions Europe vis-à-vis its competitors Low literacy skills Low numeracy skills EU-20 United States Canada Korea Australia Norway New Zealand
More informationEuropean Commission Renewable Energy Policy The Renewables Roadmap Tom Howes, DG TREN European Sustainable Energy Policy Seminar, March 20, 2007
European Commission Renewable Energy Policy The Renewables Roadmap Tom Howes, DG TREN European Sustainable Energy Policy Seminar, March 20, 2007 Organised by INFORSE, EUFORES, EREF www.inforse.org/europe/seminar07_bxl.htm
More informationISSN energy. in figures. Energy
ISSN 1977-4559 EU energy in figures STATISTICAL POCKETBOOK 2014 Energy EU ENERGY IN FIGURES POCKETBOOK 2014 1 This publication does not involve the European Commission in liability of any kind. Europe
More informationFOCUS AREA 5E: Carbon conservation / sequestration
Rural Development Programmes 2014-2020: Key facts & figures FOCUS AREA 5E: Carbon conservation / sequestration 1. Introduction Focus Area (FA) 5E is designed to support actions that foster carbon conservation
More informationCross-border Mobility of Young Researchers
Cross-border Mobility of Young Researchers Kimmo Viljamaa European Parliament ITRE Committee meeting 15 October, 2009 Advansis Oy Logotech SA i.con. innovation GmbH Mr Kimmo Viljamaa & Mr Kimmo Halme Mr
More informationUse of Economic Instruments (EIs) and Waste Management Performances. Stakeholder event, 25 October Emma Watkins, IEEP
Use of Economic Instruments (EIs) and Waste Management Performances Stakeholder event, 25 October 2011 Emma Watkins, IEEP IEEP with BIO Intelligence Service, Ecologic, Umweltbundesamt, Arcadis and Eunomia
More informationThe CAP towards Implementation of Rural Development Policy. State of Play of RDPs
The CAP towards 2020 Implementation of Rural Development Policy State of Play of RDPs Disclaimer The synthesis presented in the following slides reflects the data submitted by Member States and Regions
More informationClimate Action and Renewable Energy Package
Climate Action and Renewable Energy Package Objectives agreed for 2020 20% GHG reduction compared to 1990 ª Independent commitment 30% GHG reduction compared to 1990 ª In context of international agreement
More informationCAP CONTEXT INDICATORS
CAP CONTEXT INDICATORS 2014-2020 33. FARMING INTENSITY 2017 update CONTEXT INDICATOR 33: FARMING INTENSITY Intensification is an important restructuring process that has characterised European agriculture
More informationAre EMEA banks prepared for the new world of banking? Benchmarking
Are EMEA banks prepared for the new world of banking? Benchmarking institutions Partner Partner & Corporate Finance Partner Technology & Enterprise Application Xavier Turquin & Corporate Finance Daniel
More informationAgencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Spain)
DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Spain) PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
More informationThe Future of Food and Farming
The Future of Food and Farming Communication from the Commission DG Agriculture and Rural Development European Commission Guido Castellano #FutureofCAP 2 Challenges and opportunities Overall context Farm
More informationGVP Module X - additional monitoring of medicines
GVP Module X - additional monitoring of medicines 6 th Stakeholders forum on the implementation of the new pharmacovigilance legislation Mick Foy, Group Manager - MHRA An agency of the European Union Contents
More informationEvaluation of the National Renewable Energy Action Plans
www.aebiom.org Evaluation of the National Renewable Energy Action Plans Jean-Marc Jossart Copenhagen, 6 October 2010 About AEBIOM European Biomass Association Represents and promotes interests of bioenergy
More informationCOMMISSION STAFF WORKING DOCUMENT Accompanying the document
EUROPEAN COMMISSION Brussels, 14.12.2017 SWD(2017) 445 final PART 2/2 COMMISSION STAFF WORKING DOCUMENT Accompanying the document REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE
More information% of Reference Price 190% Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Beef & Veal Production (E28 Slaughtering) - Tonnes
Iran EU Iran EU Trade Japan Japan South Korea Tonnes cw in Tonnes cwe South Korea Qty in 1 Tonnes World Trade -8.4% Production Production & Stocks -1.8% -4.2% -4.2% -.6% EU Uruguay Paraguay Iran EU Paraguay
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR AGRICULTURE AND RURAL DEVELOPMENT. Directorate B. Quality, Research & Innovation, Outreach Acting Director
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR AGRICULTURE AND RURAL DEVELOPMENT Directorate B. Quality, Research & Innovation, Outreach Acting Director Ref. Ares(207)269098-23/05/207 Brussels, EP/sn/agri.ddg.b.4(207)298656
More informationenergy in figures Energy
EU energy in figures Statistical pocketbook 2015 Energy This publication does not involve the European Commission in liability of any kind. Europe Direct is a service to help you find answers to your questions
More informationEUROPEAN COMMISSION Implementation of the NRF in C&E European countries
EUROPEAN COMMISSION Implementation of the NRF in C&E European countries Some regional particularities? Vilnius 5 October 2004 George Papapavlou Head of unit Implementation of the Regulatory Framework (II)
More informationEU Water Framework Directive
EU Water Framework Directive Overview and state of implementation TAIEX Seminar on the Water Framework and Urban Waste Water Directive Zagreb, 25-26 September 2008 Jorge Rodríguez Romero European Commission,
More informationEducation and training as a gateway to the labour market: Making inclusion real. Vocational education and training and social inclusion
Education and training as a gateway to the labour market: Making inclusion real Vocational education and training and social inclusion Aviana Bulgarelli, Director Cedefop 1 Low-qualified people EU27- Changes
More information% of Reference Price 190% Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Beef & Veal Production (E28 Slaughtering) - Tonnes
Trade Prices Production Production & Stocks DG AGRI DASHBOARD: BEEF AND VEAL Last update: 5.1.217 Carcasse Live Animals 3.2% 1.7% -6.3% -4.2% -1.8% -7.3% 4.2% /1 kg Tonnes cw /head /kg 16.5% 1.5% -1.6%
More informationCAP CONTEXT INDICATORS
CAP CONTEXT INDICATORS 2014-2020 40. WATER QUALITY 2017 update CONTEXT INDICATOR 40: WATER QUALITY Water quality is assessed through the Gross Nutrient Balance and nitrates in freshwater The nitrogen surplus
More information% of Reference Price 190% Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Beef & Veal Production (E28 Slaughtering) - Tonnes
EU Trade Japan South Korea Russia (up to Mar) Chile (up to Mar) EU Chile (up to Mar) in Tonnes cwe Japan South Korea Russia (up to Mar) Tonnes cw Qty in 1 Tonnes World Trade China + H. Kong China + H.
More informationStudy of VET graduate tracking measures in EU Member States
Study of VET graduate tracking measures in EU Member States Final findings European Commission. DG EMPL 21 November 2017 EQAVET Forum Shane Beadle In association with What will be covered Context for the
More informationWaste or Resource? The path to a Circular Economy and Sustainability
Waste or Resource? The path to a Circular Economy and Sustainability 25 September 2014 Vanya Veras Secretary General Municipal Waste Europe Municipal Waste Europe is a non-profit association which represents
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR AGRICULTURE AND RURAL DEVELOPMENT
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR AGRICULTURE AND RURAL DEVELOPMENT Directorate B. Multilateral relations, quality policy The Director Brussels, JO/sn/agri.ddg.b.4(05)40549 Short report of the
More informationExplanatory note on general fees payable to the European Medicines Agency
Explanatory note on general fees payable to the European Medicines Agency The fees, fee exemptions and definitions described in this explanatory note apply as of 1 June 2017 and are based on Council Regulation
More informationElectricity sector transformation in Europe Taking local idiosyncrasies into account
Electricity generation in TWh IAEE Vienna September 217 4.5 4. 3.5 3. 2.5 2. 1.5 1. 5 215 22 225 23 235 24 245 25 Electricity sector transformation in Europe Taking local idiosyncrasies into account Clemens
More informationEU Bioenergy policy. COMPETE: Bioenergy for sustainable development in Africa. Ewout Deurwaarder, European Commission EUROPEAN COMMISSION
EU Bioenergy policy COMPETE: Bioenergy for sustainable development in Africa Ewout Deurwaarder, European Commission EUROPEAN COMMISSION Brussels, 2411/2009 Policy background.renewable Energy promotion
More informationKEY FIGURES June 2011
KEY FIGURES June 2011 1 KEY FIGURES Content 1. ENERGY IN THE WORLD 2. EU ENERGY DEPENDENCY 3. EU ENERGY CONSUMPTION BY FUEL 4. EU FINAL ENERGY CONSUMPTION 5. EU ENERGY PRODUCTION 6. EU ELECTRICITY GENERATION
More informationGDPR Implementation. State of play in the Member States on 6 December 2017
GDPR Implementation State of play in the Member States on 6 December 2017 AT BE BG CZ public CY public DE The law covering both, the GDPR and the Police Directive, has been adopted by Parliament and will
More informationRural Development Policy
Rural Development Policy Guido CASTELLANO Deputy Head of Unit H1 Consistency of Rural Development DG Agriculture and Rural Development European Commission Agriculture and Rural Development Importance of
More informationOn 19/06/2012 the Court delivered its ruling in Case C-307/10 "IP Translator", giving the following answers to the referred questions:
Common Communication on the Common Practice on the General Indications of the Nice Class Headings v1.2, 1 28 October 2015 On 19/06/2012 the Court delivered its ruling in Case C-307/10 "IP Translator",
More informationI) Background information. 1. Age
Results of questionnaire for the general public on the revision of Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes I) Background information 1. Age
More informationThe European Employment Strategy More and better jobs for all
The European Employment Strategy More and better jobs for all European Commission What is the EES? The European Employment Strategy (EES) was created with the aim to orientate and ensure co-ordination
More information% of Reference Price 190% Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Beef & Veal Production (E28 Slaughtering) - Tonnes
EU Trade South Korea Malaysia (up to Sep) EU Japan Japan South Korea Malaysia (up to Sep) in Tonnes cwe Russia (up to Oct) Mexico (up to Sep) Russia (up to Oct) Mexico (up to Sep) Tonnes cw Qty in 1 Tonnes
More informationDr Derek Hutcheson (University College Dublin)
REPORT ON FRANCHISE AND ELECTORAL PARTICIPATION OF THIRD COUNTRY CITIZENS RESIDING IN THE EUROPEAN UNION AND OF EU CITIZENS RESIDING IN THIRD COUNTRIES: The external voting rights of non-resident first
More informationLegislative Framework and Scientific Guidance in European Assessment
Legislative Framework and Scientific Guidance in European Assessment Riccardo Luigetti Quality Assessors Training London 26 October 2009 1 Content of the presentation Scientific guidelines Other related
More informationEuropean Parliament Eurobarometer (Standard EB 74.3 on Energy)
Directorate General for Communication Direction C - Relations with citizens Public Opinion Monitoring Unit Brussels, 31 January 2011 Parlemeter January 2011 European Parliament Eurobarometer (Standard
More informationConsumer flash estimates
European Commission Directorate General Economic and Financial Affairs Consumer flash estimates Roberta Friz EU WORKSHOP ON RECENT DEVELOPMENTS IN BUSINESS AND CONSUMER SURVEYS Brussels, 14 October 2009
More informationCARE database. Maria Teresa Sanz Villegas European Commission 6/7/
Maria Teresa Sanz Villegas European Commission n 1 1.Background 2.Process & data 3.Security 4.CaDAS 5.Europa site n 2 towards a common tool for a better monitoring of road accidents Council Decision 93/704/EC
More informationEMA/CMDh EXPLANATORY NOTES ON VARIATION APPLICATION FORM (Human medicinal products only)
EMA/CMDh EXPLANATORY NOTES ON VARIATION APPLICATION FORM (Human medicinal products only) Doc. Ref.: CMDh/EMA/133/2010/Rev4 October 2010 INTRODUCTION AND GENERAL COMMENTS This document is intended to provide
More informationModelling Biomass in TIMES models
Modelling Biomass in TIMES models Hilke Rösler, Sander Lensink Amsterdam 22 th October 2007 www.ecn.nl Introduction NEEDS project: building 29 country models, representation of the complete energy system
More informationFirst movers experiences with gender pay transparency measures in Europe
First movers experiences with gender pay transparency measures in Europe Dr. Isabella Biletta, Dr. Christine Aumayr-Pintar National Symposium on the Gender Pay Gap Iveagh House, Dublin, 10 January 2018
More information% of Reference Price 190% Avg Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec. Male Calves Dairy Type Male Calves Beef Type
EU Canada Chile Chile EU Canada Trade Tonnes cw in Tonnes cwe In Tonnes cwe Russia (up to Aug) Japan Mexico (up to Aug) South Korea Russia (up to Aug) Japan Mexico (up to Aug) South Korea Qty in 1 Tonnes
More informationGuide to Fees for Veterinary Products
Guide to Fees for Veterinary Products FIN-G0003-16 2 JANUARY 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS ABBREVIATIONS
More information